Logo of no_image_available

S3. BETA-2 AGONISTS

All selective and non-selective beta-2 agonists, including all optical isomers, are prohibited.

Including, but not limited to:

  • Arformoterol
  • Fenoterol
  • Formoterol
  • Higenamine
  • Indacaterol
  • Levosalbutamol
  • Olodaterol
  • Procaterol
  • Reproterol
  • Salbutamol
  • Salmeterol
  • Terbutaline
  • Tretoquinol (trimetoquinol)
  • Tulobuterol
  • Vilanterol

EXCEPTIONS

  • Inhaled salbutamol: maximum 1600 micrograms over 24 hours in divided doses not to exceed 600 micrograms over 8 hours starting from any dose;
  • Inhaled formoterol: maximum delivered dose of 54 micrograms over 24 hours;
  • Inhaled salmeterol: maximum 200 micrograms over 24 hours;
  • Inhaled vilanterol: maximum 25 micrograms over 24 hours.

NOTE:

The presence in urine of salbutamol in excess of 1000 ng/mL or formoterol in excess of 40 ng/mL is not consistent with therapeutic use of the substance and will be considered as an Adverse Analytical Finding (AAF) unless the Athlete proves, through a controlled pharmacokinetic study, that the abnormal result was the consequence of a therapeutic dose (by inhalation) up to the maximum dose indicated above.